Advanced Enzyme Technologies Q3 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
327.30
-7.10 (-2.12%)
-7.10 (-2.12%)Volume9.91 K
Updated: Fri 24 Jan, 2025 | 15:29:56
NSE
327.70-6.35 (-1.90%)
-6.35 (-1.90%)Volume2.44 L
Updated: Fri 24 Jan, 2025 | 15:30:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Advanced Enzyme Technologies Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 160.94 | 157.84 | 1.96% | 142.11 | 13.25% |
| Selling/ General/ Admin Expenses Total | 32.13 | 31.68 | 1.40% | 29.03 | 10.65% |
| Depreciation/ Amortization | 8.60 | 8.73 | -1.41% | 9.13 | -5.75% |
| Other Operating Expenses Total | 39.98 | 37.84 | 5.66% | 33.91 | 17.92% |
| Total Operating Expense | 115.78 | 115.26 | 0.45% | 109.55 | 5.68% |
| Operating Income | 45.16 | 42.59 | 6.04% | 32.56 | 38.68% |
| Net Income Before Taxes | 58.88 | 47.93 | 22.85% | 40.45 | 45.54% |
| Net Income | 41.77 | 34.41 | 21.41% | 29.44 | 41.91% |
| Diluted Normalized EPS | 3.74 | 3.08 | 21.43% | 2.63 | 42.21% |